BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
222 results:

  • 1. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
    Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
    Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
    Zhang Q; Zhang R; Li Y; Yang X
    J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TMED3 stabilizes smad2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
    Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
    Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
    Wang Y; Zhang A; Li Q; Liu C
    J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
    Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
    BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
    Dos Santos MV; Holth A; Bischof K; Davidson B
    Clin Exp Metastasis; 2024 Feb; 41(1):69-76. PubMed ID: 38141113
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Somatostatin Inhibited the EMT of Pancreatic cancer Cells by Mediating the TGF-β/Smad Signaling Pathway.
    Zhou X; Wang W; Liu L
    Discov Med; 2023 Dec; 35(179):1086-1092. PubMed ID: 38058074
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
    Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
    Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BRD9-smad2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
    Feng Y; Cai L; Pook M; Liu F; Chang CH; Mouti MA; Nibhani R; Militi S; Dunford J; Philpott M; Fan Y; Fan GC; Liu Q; Qi J; Wang C; Hong W; Morgan H; Wang M; Sadayappan S; Jegga AG; Oppermann U; Wang Y; Huang W; Jiang L; Pauklin S
    Gastroenterology; 2024 Jan; 166(1):139-154. PubMed ID: 37739089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
    Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
    Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
    Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
    Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.
    Braun R; Lapshyna O; Watzelt J; Drenckhan M; Künstner A; Färber B; Hael AAM; Bolm L; Honselmann KC; Konukiewitz B; Castven D; Spielmann M; Gorantla SP; Busch H; Marquardt JU; Keck T; Wellner UF; Ungefroren H
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831254
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse.
    Ziverec A; Chanal M; Raymond P; Ilie MD; De Alcubierre D; Pasternack A; Ritvos O; Raverot G; Bertolino P
    Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36633456
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition.
    Li G; Yi X; Du S; Gong L; Wu Q; Cai J; Sun S; Cao Y; Chen L; Xu L; Wang Z
    Oncogene; 2023 Feb; 42(6):421-433. PubMed ID: 36482201
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epigenome-wide association analysis of pancreatic exocrine cells from high-fat- and normal diet-fed mice and its potential use for understanding the oncogenesis of human pancreatic cancer.
    Araki T; Nagashima M; Hirasawa H; Tamalu F; Katagiri Y; Miwa N
    Biochem Biophys Res Commun; 2022 Dec; 637():50-57. PubMed ID: 36375250
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. smad2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
    Bertrand-Chapel A; Caligaris C; Fenouil T; Savary C; Aires S; Martel S; Huchedé P; Chassot C; Chauvet V; Cardot-Ruffino V; Morel AP; Subtil F; Mohkam K; Mabrut JY; Tonon L; Viari A; Cassier P; Hervieu V; Castets M; Mauviel A; Sentis S; Bartholin L
    Commun Biol; 2022 Oct; 5(1):1068. PubMed ID: 36207615
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hyperthermia-induced stellate cell deactivation to enhance dual chemo and pH-responsive photothermal therapy for pancreatic cancers.
    Hu Q; Xu M; Feng J; Xie H; Li J; He Y; Tang G; Guo B
    Nanoscale; 2022 Nov; 14(42):15735-15748. PubMed ID: 36205175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
    Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
    Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian cancer by Reducing smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.
    Rao Y; Zhang W; Li D; Li X; Ma Y; Qu P
    Contrast Media Mol Imaging; 2022; 2022():1032557. PubMed ID: 36072623
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TRPC1 channels regulate the activation of pancreatic stellate cells through ERK1/2 and smad2 pathways and perpetuate their pressure-mediated activation.
    Radoslavova S; Fels B; Pethö Z; Gruner M; Ruck T; Meuth SG; Folcher A; Prevarskaya N; Schwab A; Ouadid-Ahidouch H
    Cell Calcium; 2022 Sep; 106():102621. PubMed ID: 35905654
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.